SANGAMO THERAPEUTICS, INC License Agreements
15 Contracts & Agreements
- License Agreement between the Company and Genentech, Inc., dated August 2, 202 (Filed With SEC on November 12, 2024)
- First Amendment to the License Agreement (Filed With SEC on October 27, 2016)
- EIGHTH AMENDMENT TO THE RESEARCH AND COMMERCIAL LICENSE OPTION AGREEMENT (Filed With SEC on October 27, 2016)
- sEVENTH AMENDMENT TO THE LICENSE AGREEMENT (Filed With SEC on August 6, 2015)
- FIFTH AMENDMENT TO THE LICENSE AGREEMENT (Filed With SEC on May 9, 2013)
- FOURTH AMENDMENT TO THE LICENSE AGREEMENT (Filed With SEC on November 2, 2012)
- SEVENTH AMENDMENT OF THE RESEARCH AND COMMERCIAL LICENSE OPTION AGREEMENT (Filed With SEC on February 17, 2011)
- THIRD AMENDMENT TO THE LICENSE AGREEMENT (Filed With SEC on November 6, 2009)
- SECOND AMENDMENT OF THE LICENSE AGREEMENT (Filed With SEC on November 6, 2009)
- FIRST AMENDMENT OF THE LICENSE AGREEMENT (Filed With SEC on November 6, 2009)
- LICENSE AGREEMENT (Filed With SEC on March 3, 2009)
- RESEARCH AND LICENSE AGREEMENT (Filed With SEC on November 4, 2008)
- LICENSE AGREEMENT (Filed With SEC on August 7, 2008)
- SECOND RESEARCH AND LICENSE AGREEMENT BETWEEN GENENTECH, INC. (Filed With SEC on May 9, 2008)
- SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on March 27, 2003)
